Generic Sweden ABOMXSTO: GENI

GENI: Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand

· Issued by Generic Sweden AB

Record Q3 2024 with 24% revenue growth, highest-ever EBITDA, and improved margins. SaaS product DOCS and RCS pilots drive future growth, with strong demand in core verticals.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Generic Sweden AB on 6ix

Earlier from Generic Sweden

Later from Generic Sweden

All Generic Sweden news releases